David M. Berman - 02 Jan 2024 Form 3 Insider Report for Immunocore Holdings plc (IMCR)

Role
Head of R&D
Signature
/s/ David Berman
Issuer symbol
IMCR
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2024, 16:43:50 UTC
Next filing
21 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 391,790 $17.46 Direct F1
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 468,623 $26.00 Direct F2
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 134,271 $24.66 Direct F3
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 90,599 $64.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 25% of the shares subject to the option award vested on February 4, 2022, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F3 25% of the shares subject to the option award vested on February 16, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F4 25% of the shares subject to the option award shall vest on February 16, 2024, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney